Back to Journals Risk Management and Healthcare Policy Volume 17 Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus Authors Xie Z , Hu J, Li M, Hu X , Chen J Received 20 December 2023 Accepted for publication 17 April 2024 Published 23 April 2024 Volume 2024:17 Pages 10531067 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Jongwha Chang Zeyu Xie, Jia Hu, Mengting Li, Xiao Hu, Jisheng Chen Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Peoples Republic of China Correspondence: Jisheng Chen, Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, Peoples Republic of China, Tel +86 20-87622305, Fax +86 20-61321967, Email [email protected] Purpose: This study provides a reference for healthcare organizations in the selection and rational use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), based on the Rapid Guide for Drug Evaluation and Selection in Chinese Medical Institutions (Second Edition)
7 Seminal vesicles, prostate gland, and bulbourethral glands
Metformin can interfere with B12 absorption, which can lead to low levels of B12 over time
Preclinical and observational data available for the individual components
